GeneDx is a leading brand in the field of genomic and clinical testing, dedicated to providing faster diagnoses and more precise care plans for patients. With a focus on delivering personalized, actionable insights, GeneDx utilizes its decades of genomic expertise and cutting-edge data science to interpret clinical data at scale. One of GeneDx's key offerings is its exome and genome testing, which is considered among the best in the industry.

Through their innovative health information platform, Centrellis®, GeneDx leverages millions of medical records and integrates digital tools with artificial intelligence to synthesize clinical and genomic data. This comprehensive approach allows GeneDx to develop a more complete understanding of complex diseases, leading to faster diagnoses, more effective treatment plans, and enhanced drug discovery. GeneDx's offerings benefit a wide range of healthcare partners, including clinicians, researchers, health systems, pharmaceutical companies, and payors.

By improving patient experiences and advancing population health, GeneDx plays a crucial role in improving health outcomes for all. With over 20 years of experience, GeneDx has been a pioneer in genomic testing and has built one of the deepest and most sophisticated datasets in the industry. Their proprietary interpretation platform, coupled with custom analysis algorithms and expert data curation, ensures highly accurate genome and exome testing.

GeneDx's trajectory is focused on continuing to improve the lives of rare disease patients through genomic testing, with a particular emphasis on pediatric and outpatient NICU testing. However, they believe that everyone can benefit from exome and genome testing and envision a future healthcare system where personalized health plans and treatment options are based on an individual's genomic profile and clinical data. Partner with GeneDx for advanced genomic and clinical testing that leads to faster diagnoses, improved treatment plans, and enhanced outcomes